BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 512040)

  • 1. Significance of serum complement levels in patients with gastrointestinal disease.
    Ross IN; Thompson RA; Montgomery RD; Asquith P
    J Clin Pathol; 1979 Aug; 32(8):798-801. PubMed ID: 512040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Humoral immune system in inflammatory bowel disease: I. Complement levels.
    Hodgson HJ; Potter BJ; Jewell DP
    Gut; 1977 Sep; 18(9):749-53. PubMed ID: 604196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum C3 and C4 complement components in ulcerative colitis and Crohn's disease.
    Ward M; Eastwood MA
    Digestion; 1975; 13(1-2):100-3. PubMed ID: 1201816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humoral immune system activity in inflammatory bowel disease.
    Teisberg P; Gjone E
    Scand J Gastroenterol; 1975; 10(5):545-9. PubMed ID: 1171519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The alternate complement pathway in inflammatory bowel disease. Quantitation of the C3 proactivator (factor B) protein.
    Feinstein PA; Kaplan SR; Thayer WR
    Gastroenterology; 1976 Feb; 70(2):181-5. PubMed ID: 2509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement alterations in inflammatory bowel disease.
    Lake AM; Stitzel AE; Urmson JR; Walker WA; Spitzer RE
    Gastroenterology; 1979 Jun; 76(6):1374-9. PubMed ID: 437435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High normal serum levels of C3 and C1 inhibitor, two acute-phase proteins belonging to the complement system, occur more frequently in patients with Crohn's disease than ulcerative colitis.
    Bene L; Füst G; Fekete B; Kovács A; Horváth L; Prohászka Z; Miklós K; Pálos G; Daha M; Farkas H; Varga L
    Dig Dis Sci; 2003 Jun; 48(6):1186-92. PubMed ID: 12822883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypercatabolism of complement in Crohn's disease--assessment of circulating C3c.
    Elmgreen J; Berkowicz A; Sørensen H
    Acta Med Scand; 1983; 214(5):403-7. PubMed ID: 6660048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serum complement levels in ulcerative colitis].
    Díaz-Rubio García M; Díaz-Rubio García E; Candel Monserrate I; Erroz Serrano A
    Rev Clin Esp; 1980 Feb; 156(4):241-3. PubMed ID: 7394204
    [No Abstract]   [Full Text] [Related]  

  • 10. Polymorphism of complement C3 in chronic inflammatory bowel disease. Predominance of the C3F gene in Crohn's disease.
    Elmgreen J; Sørensen H; Berkowicz A
    Acta Med Scand; 1984; 215(4):375-8. PubMed ID: 6731047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistological differential diagnosis of inflammatory colonic diseases.
    Schneider HM; Loos M; Störkel S; Gross M
    Histopathology; 1984 Jul; 8(4):583-8. PubMed ID: 6332771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of classical pathway complement in chronic inflammation. Elevated levels of circulating C3d and C4d split products in rheumatoid arthritis and Crohn's disease.
    Petersen NE; Elmgreen J; Teisner B; Svehag SE
    Acta Med Scand; 1988; 223(6):557-60. PubMed ID: 3389208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement inhibitors and immunoconglutinins in ulcerative colitis and Crohn's disease.
    Potter BJ; Brown DJ; Watson A; Jewell DP
    Gut; 1980 Dec; 21(12):1030-4. PubMed ID: 6450718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Humoral immunologic changes in inflammatory colonic diseases].
    Matos M; Capozzolo N; Golindano C; González JC; Guirola E; Ramirez R; Machado I
    G E N; 1993; 47(3):129-35. PubMed ID: 8112548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular hypersensitivity to components of intestinal mucosa in ulcerative colitis and Crohn's disease.
    Bendixen G
    Gut; 1969 Aug; 10(8):631-6. PubMed ID: 5810973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surface epithelium related activation of complement differs in Crohn's disease and ulcerative colitis.
    Halstensen TS; Mollnes TE; Garred P; Fausa O; Brandtzaeg P
    Gut; 1992 Jul; 33(7):902-8. PubMed ID: 1379568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secretory immunoglobulin deficiency in a family with inflammatory bowel disease.
    Engstrom JF; Arvanitakis C; Sagawa A; Abdou NI
    Gastroenterology; 1978 Apr; 74(4):747-51. PubMed ID: 415931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological studies in inflammatory bowel disease.
    Pepys MB; Druguet M; Klass HJ; Dash AC; Mirjah DD; Petrie A
    Ciba Found Symp; 1977 Apr 26-28; (46):283-304. PubMed ID: 346325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced local production of complement components in the small intestines of patients with Crohn's disease.
    Ahrenstedt O; Knutson L; Nilsson B; Nilsson-Ekdahl K; Odlind B; Hällgren R
    N Engl J Med; 1990 May; 322(19):1345-9. PubMed ID: 2325733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating immune complexes in Crohn's disease. Their characterization and interrelationship with components of the complement system.
    Richens ER; Thorp CM; Bland PW; Hall ND
    Dig Dis Sci; 1982 Feb; 27(2):129-38. PubMed ID: 7075407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.